跳至主要内容
临床试验/PACTR202307876581314
PACTR202307876581314尚未招募4 期

Postpartum IV Iron to Treat Iron Deficiency Anemia Post Delivery (PRIORITY TRIAL). A Randomized Controlled Trial Of The Global Network For Women's and Children's Health Research Version 0.7 December 14, 2021

ational Institute of Child Health and Development0 个研究点目标入组 600 人开始时间: 2023年7月6日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • Established pregnancy >20 wk gestation by LMP and/or clinical assessment and/ Or USG
  • Age: 15 years (or lower limit age eligible*) to 49 years
  • Confirmed moderate anemia (Hb 7.0 to 9.9 g/dL, 6-48 hr after delivery based on a venous
  • blood sample on Hemocue®)
  • Deliver in participating study hospital or health facility
  • Able to provide informed consent
  • Plans to remain in study area for duration of the study

排除标准

  • IV Iron infusion already received in past 3 weeks
  • Contraindication to iron supplementation (some examples may include hemolytic
  • anemia, allergy, severe infection)
  • Blood transfusion already received or scheduled in the current hospital admission
  • Known diagnosis of pre-existing depression or other psychiatric illness
  • Stillbirth, major congenital anomaly, or neonatal loss prior to randomization
  • Women testing positive and previously untreated for malaria
  • Presenting with symptomatic anemia with dyspnea or fatigue and need for immediate
  • Women with known hemoglobinopathy (sickle cell disease or thalassemia)
  • Presence of severe allergic conditions such as severe asthma or known drug allergies
  • Women presenting with any illness/condition requiring immediate medical care per
  • physician’s assessment

研究者

发起方
ational Institute of Child Health and Development

相似试验